Individualized Approach vs. Fixed Approach

Inclusion criteria

• Age ≥18 years
• The patient understands the nature of the study, treatment procedure and provides written informed consent
• Symptomatic paroxysmal atrial fibrillation as defined by the current guidelines
• Willing to comply with specified pre-, post- and follow-up testing, evaluations and requirements
• Expected to remain available (geographically stable) for at least 12 months after enrollment

Exclusion criteria

• Atrial fibrillation secondary to a reversible cause or of non-cardiac origin
• Previous AF ablation procedure
• Longstanding persistent AF
• Documented left atrial thrombus on imaging (e.g., transesophageal echocardiogram, angiogram)
• NYHA functional Class IV heart failure
• Unstable angina
• Left ventricular ejection fraction < 30%
• Valvular disease requiring interventional treatment
• Cardiac surgery within 3 months prior to enrolment
• Left atrial size > 55 mm as measured in the parasternal antero-posterior view
• Uncontrolled bleeding, diathesis, coagulopathy or pro-coagulant state
• Active systemic infection or sepsis
• Other co-morbid condition(s) that could limit the participant's ability to participate in the study or to comply with follow-up requirements, or impact the scientific integrity of the study.